Literature DB >> 9808242

Association of resistance to activated protein C and dural arteriovenous fistulas.

J A Kraus1, B K Stüper, P Berlit.   

Abstract

Resistance to activated protein C (APCR), shown to be the most common genetic risk factor for venous thrombosis, is mostly caused by a mutation in the factor V (FV) gene leading to FV Leiden. As dural arteriovenous fistulas (DAVFs) are associated with cerebral venous thrombosis, we looked for the FV Leiden mutation in seven patients with such fistulas. The APCR ratio was determined according to standard procedures. For APCR ratios considered pathological (less than 2.0), mutation analysis was done by a reverse hybridization assay. Three of the seven patients with DAVFs showed pathological APCR ratios and heterozygosity for FV Leiden mutation. Thus, it is hypothesized that FV Leiden might be involved in the pathogenesis of DAVFs.

Entities:  

Mesh:

Year:  1998        PMID: 9808242     DOI: 10.1007/s004150050276

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  6 in total

1.  Frequency and characteristics associated with inherited thrombophilia in patients with intracranial dural arteriovenous fistula.

Authors:  Sara C LaHue; Helen Kim; Ludmila Pawlikowska; Jeffrey Nelson; Daniel L Cooke; Steven W Hetts; Vineeta Singh
Journal:  J Neurosurg       Date:  2018-04-01       Impact factor: 5.115

2.  Reconstructive treatment of dural arteriovenous fistulas of the transverse and sigmoid sinus: transvenous angioplasty and stent deployment.

Authors:  T Liebig; H Henkes; S Brew; E Miloslavski; M Kirsch; D Kühne
Journal:  Neuroradiology       Date:  2005-05-20       Impact factor: 2.804

3.  Diagnosis and treatment of dural carotid-cavernous fistulas: a consecutive series of 27 patients.

Authors:  M Théaudin; J-P Saint-Maurice; R Chapot; K Vahedi; M Mazighi; C Vignal; G Saliou; C Stapf; M-G Bousser; E Houdart
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-10-06       Impact factor: 10.154

4.  Incidental discovery of a dural arteriovenous fistula in a patient with activated protein C resistance.

Authors:  Jason D Wenderoth; Constantine C Phatouros
Journal:  AJNR Am J Neuroradiol       Date:  2003-08       Impact factor: 3.825

5.  Thrombophilia Due to Factor V and Factor II Mutations and Formation of a Dural Arteriovenous Fistula: Case Report and Review of a Rare Entity.

Authors:  Sam Safavi-Abbasi; Federico Di Rocco; Peter Nakaji; Guenther C Feigl; Alireza Gharabaghi; Madjid Samii; Anton Valavanis; Amir Samii
Journal:  Skull Base       Date:  2008-03

6.  Coil embolization of cavernous sinus in patients with direct and dural arteriovenous fistula.

Authors:  Andrea Bink; Joachim Berkefeld; Marc Lüchtenberg; Rüdiger Gerlach; Tobias Neumann-Haefelin; Friedhelm Zanella; Richard du Mesnil de Rochemont
Journal:  Eur Radiol       Date:  2009-01-10       Impact factor: 5.315

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.